The Lancet publishes Lundbeck Vyepti study
![Photo: Lundbeck / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14151484.ece/ALTERNATES/schema-16_9/doc7lghxre1gvrs3n0i6ex.jpg)
The Lancet, a top-ranking medical journal, has published results from pharmaceutical firm Lundbeck’s Deliver study of migraine drug Vyepeti, the firm announced in a press release on Thursday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.